Anaptysbio (ANAB) Return on Invested Capital (2018 - 2026)

Anaptysbio has reported Return on Invested Capital for 7 years, with the latest figure at 0.02% in Q1 2026.

• For the quarter ending Q1 2026, Return on Invested Capital rose 2.0% year-over-year to 0.02%; the trailing twelve-month figure through Mar 2026 stood at 0.02% (up 2.0% YoY), and the FY2024 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital for Q1 2026 stood at 0.02%, up from 0.02% in the prior quarter.
• The five-year high for Return on Invested Capital was 0.02% in Q1 2026, with the low at 0.02% in Q3 2025.
• Historically, Return on Invested Capital has averaged 0.0% across 4 years, with a median of 0.0% in 2024.
• Annual changes were most pronounced in 2025 — Return on Invested Capital slipped 1 bps — and 2026, when it gained 2 bps.
• Anaptysbio's Return on Invested Capital stood at 0.0% in 2023, then dropped by 19 bps to 0.0% in 2024, then plunged by 283 bps to 0.02% in 2025, then surged by 210 bps to 0.02% in 2026.
• The last three Return on Invested Capital figures came in at 0.02% (Q1 2026), 0.02% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.